ПРОГНОЗ ПРОДОЛЖИТЕЛЬНОСТИ ЖИЗНИ ПРИ МЕТАСТАТИЧЕСКОМ НЕМЕЛКОКЛЕТОЧНОМ РАКЕ ЛЕГКОГО
##article.numberofdownloads## 29
##article.numberofviews## 56
PDF (Русский)

关键词

РАК ЛЕГКОГО
ГЕМОПОЭТИЧЕСКИЕ СТВОЛОВЫЕ КЛЕТКИ
ПРОГНОЗ
ПРОДОЛЖИТЕЛЬНОСТЬ ЖИЗНИ

How to Cite

Шутко, А., & Мус, В. (2018). ПРОГНОЗ ПРОДОЛЖИТЕЛЬНОСТИ ЖИЗНИ ПРИ МЕТАСТАТИЧЕСКОМ НЕМЕЛКОКЛЕТОЧНОМ РАКЕ ЛЕГКОГО. VOPROSY ONKOLOGII, 64(4), 522–527. https://doi.org/10.37469/0507-3758-2018-64-4-522-527

摘要

У пациентов с метастатическим немелкоклеточным раком легкого ретроспективно сопоставлены индивидуальные параметры циркулирующих стволовых гемопоэтических клеток лимфоидного ряда, измеренные методом цитофлуорометрии до начала лечения, с индивидуальными продолжительностями жизни. Показана возможность прогноза результатов лечения с продолжительностью жизни <1 года со специфичностью и избирательностью, близкими к 100%.

https://doi.org/10.37469/0507-3758-2018-64-4-522-527
##article.numberofdownloads## 29
##article.numberofviews## 56
PDF (Русский)

参考

Baker H. Overtreatment in stage IV lung cancer in the UsA//The Lancet oncology. -2015. -Vol. 16 (15). -P. e532. - DOI: 10.1016/s1470-2045(15)00383-6

Drapeau C. Cracking the stem cell code: demystifying the most dramatic scientific breakthrough of our times.//Goodwill Books UsA, sutton Hart Press/1st. ed., 2010. Hillsboro, or -2010. -450 p.

Fliedner T. M., Graessle D. Hematopoietic cell renewal systems: mechanisms of coping and failing after chronic exposure to ionizing radiation//Radiation and Environmental Biophysics. -2008. -Vol. 47 (1). -P 63-69.

Harding C., Pompei F., Wilson R. Peak and decline in Cancer incidence, mortality, and prevalence at old ages//Cancer. -2012. -Vol. 118. -P. 1371-1386. - DOI: 10.1002/cncr.26376

Hur J., Yang H.-M., Yoon C.-H. et al. Identification of a novel role of T cells in postnatal vasculogenesis. Characterization of endothelial progenitor cell colonies//Circulation. -2007. -Vol. 116 (15). -P 1671-1682.

Koh YW., Choi J.-H., Ahn M.s. et al. Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small cell lung cancer//sci. Rep. -2016. -Vol. -P38585. - DOI: 10.1038/srep38585

Liesveld J. L., Rubin Ph., Constine L.s. Hematopoietic system, in: Adverse late effects of cancer treatment. Vol.2: Normal tissue specific sites and systems. Eds. Rubin Ph., L., Constine s., Marks L. B.//springer Verlag -Heidelberg, Germany, 2014. -P 623-656. - DOI: 10.1007/978-3-540-75863-1

Pang W.W., Price E.A., sahoo D. et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age//PNAs. -2011. -Vol. 108 (50). -P 20012-20017. -. DOI: 10.1073/pnas.1116110108

sales-Pardo I., Avenda o A., Martinez-Mu oz V. et al. Flow cytometry of the side population: tips and tricks//Cellular oncology. -2006. -Vol. 28 (1-2). -P 37-53. -. DOI: 10.1155/2006/536519

Shoutko A., Ekimova L., Mus V., sokurenko V. Fluctuations of CD34 cells number in blood of cancer patients during final year of life//Medical and Health science Journal (MHsJ) Acad. Publ. Platform. -2012. -Vol. 13(4). -P. 7-13. - DOI: 10.15208/mhsj.2012.52

Shoutko A.N., Ekimova L.P Lymphocytopenia can contribute in common benefit of cytotoxic therapy of cancer//Inter -Medical. -2014. -Vol. 3. -P 5-13. -http://www.Inter-medical.ru/files/Archiv/26-27http://www.Inter-medical.ru/files/Archiv/26-27

Shoutko A.N., Ekimova L.P The impact of middle age on the viability of patients with nonmalig-nant and malignant diseases//Cancer Research Journal. -2014. -Vol. 2(6). -P 114-120. - DOI: 10.11648/j.crj.20140206.14

Shoutko A.N., Yurkova L.E., Borodulya K.S., Ekimova L.P. Lymphocytopenia and cytotoxic therapy in patients with advanced ovarian cancer//Cancer Research Journal. -2015. -Vol. 3(3). -P47-51. - DOI: 10.11648/j.crj.20150303

Shoutko A.N., Gerasimova O.A., Ekimova L.P. et al. Long -term activation of circulating liver-committed mononuclear cells after OLT//J. J. Regener Med. -2016. -Vol. 1 (3). -P. 011.

Shoutko A.N., Gerasimova O.A., Ekimova L.P et al. Lymphocyte reproductive activity normalized to numbers of hematopoietic stem cells in blood and rate of death in fatal diseases//International Journal of Genetics and Genomics. -2017. -Vol. 5(5). -P. 54-62. - DOI: 10.11648/j.ijgg.20170505.12

Shoutko A.N., Yurkova L.E., Borodulya K.S. et al. Competitive principal of tumor control in radiological clinic//Radiol Diagn Imaging. -2017. -Vol. 1(2). -P. 1-2. - DOI: 10.15761/RDI.1000107

Sieburg H.B., Cattarossi G., Muller-sieburg C.E. Lifespan differences in hematopoietic stem cells are due to imperfect repair and unstable mean-reversion//PLos Comput Biol. -2013. -Vol. 9 (4). -P e1003006. -. DOI: 10.1371/journal.pcbi.1003006

Woolhouse I., Bishop L., Darlison L. at al. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma//BMJ thorax. -2018. -Vol. 73. -P. i1-i30. - DOI: 10.1136/thoraxjnl-2017-211321

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2018